LEWISVILLE, Texas, April 20, 2016 /PRNewswire/ -- Adeptus Health Inc. (NYSE: ADPT) ("ADPT" or the "Company"), the largest operator of freestanding emergency rooms in the U.S., announced its results for the first quarter ended March 31, 2016. All comparisons included in this release are for the same period in the prior year, unless otherwise noted. See "Non-GAAP Financial Measures Description and Reconciliation" for further information related to Systemwide Revenue, Adjusted EBITDA and Adjusted earnings per share.

http://photos.prnewswire.com/prnvar/20140625/121364

First Quarter 2016 Highlights:


    --  Systemwide net patient services revenue was $140.4 million versus $84.0
        million in prior year, an increase of 67%;
    --  Net operating revenue was $112.8 million versus $81.5 million in prior
        year, an increase of 38%;
    --  Adjusted EBITDA was $21.7 million versus $13.3 million in prior year, an
        increase of 64%;
    --  Adjusted earnings per share was $0.47 and GAAP earnings per share was
        $0.32;
    --  Cash flow used in operating activities was $7.4 million versus $12.0
        million in prior year;
    --  Net income attributable to Adeptus Health Inc. was $4.5 million versus
        $0.6 million in prior year;
    --  Same store revenue increased 12% and same store volumes increased 15%
        versus prior year, and;
    --  The Company opened seven freestanding facilities during the first
        quarter 2016.

2016 Guidance

We continue to expect systemwide net patient services revenue, which includes revenue from our unconsolidated joint ventures, of $635.0 million to $665.0 million for the full year 2016. We expect Adjusted EBITDA of $108.0 million to 113.0 million and Adjusted earnings per share of $2.50 to $2.60 for the full year 2016.

Results of Operations for the First Quarter 2016

Thomas S. Hall, Chairman and CEO, stated, "We are pleased with our first quarter results, which were in line with our expectations and demonstrate continued progress in executing on our growth plans. This quarter, we opened seven new facilities, bringing our total to 90, and achieved substantial growth in both revenue and patient volumes. With our Dallas hospital open and all of our Dallas-Fort Worth area freestanding ERs able to accept all insurance as a result, we saw significant same store volume and revenue growth, reinforcing the need for greater access to emergency medical care. Earlier this month, Fortune Magazine recognized Adeptus Health as one of the Top 20 Best Workplaces in Health Care in America. We are pleased with this acknowledgement as we continue to deliver the highest quality of care that has earned us the Press Ganey Guardian of Excellence Award in patient satisfaction for three consecutive years."

During the first quarter, ADPT opened seven new freestanding emergency facilities, including four freestanding emergency facilities in Texas, one freestanding emergency facility in Colorado, which is part of our partnership with UCHealth, and two freestanding emergency facilities in Arizona with partner, Dignity Health. Additionally, construction continues to progress on two hospitals in Colorado, one in Louisiana and one in Houston, Texas.

For the first quarter of 2016, ADPT generated total net operating revenue of $112.8 million, an increase of 38%. Net operating revenue excludes revenue from 16 facilities in Colorado, 12 of which were consolidated in the prior year, and the Arizona hospital and its six freestanding facilities, which are accounted for as equity method investments. The increase was primarily attributable to the impact of patient volumes from both existing and new consolidated freestanding facilities and annual gross charge increases, offset by the deconsolidation of our Colorado locations due to the UCHealth joint venture.

ADPT generated net income of $7.9 million for the quarter, of which $4.5 million was attributable to Adeptus Health Inc., compared to net income of $1.6 million from the prior year, of which net income of $0.6 million was attributable to Adeptus Health Inc. The increase in net income was due to an increase of $31.3 million in net operating revenue, a $3.2 million increase in equity in earnings of unconsolidated joint ventures and a $1.4 million decrease in interest expense. This increase was partially offset by increases in salaries, wages and benefits and other costs related to our growth initiatives and the impact of taxes on higher earnings.

Adjusted EBITDA increased 64% to $21.7 million. This increase was primarily attributable to a $31.3 million increase in net operating revenue and a $3.2 million increase in equity in earnings of unconsolidated joint ventures. See "Non-GAAP Financial Measures Description and Reconciliation" and "Reconciliation of Adjusted EBITDA to Net Income" below for further information related to Adjusted EBITDA and its reconciliation to net income.

Adjusted earnings per share was $0.47 per share and GAAP earnings per share was $0.32 per share for the quarter. Adjusted earnings per share is calculated using a weighted average of both Class A and Class B common shares outstanding, which was an aggregate of 20,883,876 common shares at March 31, 2016. Adjustments for the quarter include $1.9 million of preopening costs associated with new facility openings, $1.1 million of stock compensation expense and $1.1 million of other costs associated with our growth initiatives and an adjustment for taxes in order to establish a normalized tax rate of 35% for comparability purposes. See "Non-GAAP Financial Measures Description and Reconciliation" and "Earnings Per Share Reconciliation" below for further information related to Adjusted earnings per share and its reconciliation to net income.

Systemwide Financial Results

For the first quarter of 2016, ADPT generated systemwide net patient services revenue of $140.4 million, an increase of 67%. Additionally, same store revenue increased 12% and same store volumes increased 15% versus prior year. The increase in systemwide net patient services revenue was primarily attributable to the impact of increased patient volumes from the expansion of the number of freestanding facilities from 62 to 88, annual gross charge increases, the opening of a hospital in Texas and continued growth of our hospital and its hospital outpatient departments in Arizona.

As of March 31, 2016, 16 freestanding facilities associated with our joint venture with UCHealth and our Arizona hospital and its six freestanding facilities associated with our joint venture with Dignity Health were accounted for using the equity method. For consolidated subsidiaries, the Company's financial statements reflect 100% of the revenues and expenses for these subsidiaries, after elimination of intercompany transactions and accounts. For our unconsolidated joint ventures, consolidated statements of operations reflect those earnings in two line items:


    --  Equity in earnings of unconsolidated joint ventures, which represents
        our share of the net income or loss of each equity method joint venture
        based on our ownership percentage; and
    --  Management and contract services revenues, which represent the Company's
        combined income from management and contract services that are earned
        from managing the day-to-day operations and providing contract staffing
        of the facility.

As a result of this accounting treatment in our reported results, management supplementally focuses on non-GAAP systemwide metrics to analyze the results of operations. These systemwide metrics include systemwide net patient services revenue. Systemwide metrics treat our unconsolidated facilities as if they were consolidated. While the revenues earned at the unconsolidated facilities are not recorded in our consolidated financial statements, management believes systemwide net patient services revenue growth is important to understand the Company's financial performance because it is used to interpret the sources of our growth and provide a growth metric incorporating the revenues earned by all affiliated facilities, regardless of the accounting treatment. As we execute on our strategy of partnering with health systems, management expects the number of our facilities accounted for under the equity method to increase relative to the total number of affiliated facilities.

Liquidity

At the end of the first quarter, the Company had cash of $3.7 million and $39.8 million available under its revolving credit facility. Net cash flow used in operations was $7.4 million for the first quarter compared to $12.0 million net cash flow used in operations in the prior year. At March 31, 2016, the Company had total long-term debt and capital lease obligations of $123.1 million and debt net of cash of $119.4 million.

Market Outlook

We remain on track to open 27 new facilities in 2016, including both owned and joint venture facilities. These include 24 new freestanding facility openings and three new hospitals; construction on our first Louisiana-based hospital and two hospitals in Colorado remain on schedule to open by the end of the year.

"Through the continued expansion of our network of hospitals and freestanding emergency rooms and partnerships with leading healthcare organizations, we are helping to transform the delivery of emergency care in the U.S.," added Hall. "Partnerships remain a cornerstone of our growth and as 2016 unfolds we expect to announce additional partnerships."

Conference Call

A live audio webcast to present the first quarter 2016 results will take place today at 9:00 am (Eastern Time), hosted by Thomas S. Hall, Chairman and CEO, Timothy Fielding, CFO, and Graham Cherrington, President and COO.

The audio webcast will be available by accessing: https://www.webcaster4.com/Webcast/Page/1069/14443

Following the call, an archived recording of the replay will also be available on the Adeptus Health Investor Relations page for 30 days: http://ir.adeptushealth.com/events-and-presentations/events/default.aspx

About Adeptus Health Inc.

Adeptus Health (NYSE:ADPT) is a leading patient-centered healthcare organization expanding access to the highest quality emergency medical care through its network of freestanding emergency rooms and partnerships with premier healthcare providers. In Texas, Adeptus Health owns and operates First Texas Hospital and First Choice Emergency Room, the nation's largest and oldest network of independent freestanding emergency rooms. In Colorado, in partnership with University of Colorado Health, Adeptus Health operates UCHealth Emergency Rooms. In Arizona, with Dignity Health, the company operates Dignity Health Arizona General Hospital and freestanding emergency rooms. In Louisiana, Adeptus Health has a partnership with Ochsner Health System, the state's largest healthcare system, to improve access to emergency medical care. In Ohio, Adeptus Health has a partnership with Mount Carmel Health System. All Adeptus Health freestanding facilities are fully equipped emergency rooms with a complete radiology suite of diagnostic technology (CT scanner, ultrasound, and digital X-ray), on-site laboratory, and staffed with board-certified physicians and emergency trained registered nurses. According to patient feedback collected by Press Ganey Associates Inc., Adeptus Health provides the highest quality emergency medical care and received the 2013, 2014 and 2015 Press Ganey Guardian of Excellence Award for exceeding the 95th percentile in patient satisfaction nationwide. For more information please visit us on the web at adhc.com.



    Media Contact:                Jackie Zupsic

                                  Hill & Knowlton Strategies

                                  Jackie.Zupsic@hkstrategies.com

                                  Tel: (212) 885 - 0590


    Investor Relations
     Contact:                     Kevin Ellich

                                  Vice President, Investor Relations

                                  Kevin.Ellich@adhc.com

                                  Tel: (972) 899-7062

Forward-Looking Statements

Certain statements and information herein may be deemed to be "forward-looking statements" within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our guidance, objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Any forward-looking statements herein are made as of the date of this press release, and ADPT undertakes no duty to update or revise any such statements except as required by the federal securities laws. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in ADPT's filings with the U.S. Securities and Exchange Commission ("SEC") from time to time and which are accessible on the SEC's website at www.sec.gov, including in the section entitled "Risk Factors" in the Company's Form 10-K for the fiscal year ended December 31, 2015. Among the factors that could cause future results to differ materially from those provided in this press release are: our ability to implement our growth strategy; our ability to maintain sufficient levels of cash flow to meet growth expectations; our ability to protect our brand; federal and state laws and regulations relating to our facilities, which could lead to the incurrence of significant penalties by us or require us to make significant changes to our operations; our ability to locate available facility sites on terms acceptable to us; competition from hospitals, clinics and other emergency care providers; our dependence on payments from third-party payors; our ability to source and procure new products and equipment to meet patient preferences; our reliance on Medical Properties Trust ("MPT") and the MPT Master Funding and Development Agreements; disruptions in the global financial markets leading to difficulty in borrowing sufficient amounts of capital to finance the carrying costs of inventory to pay for capital expenditures and operating costs; our ability or the ability of our healthcare system partners to negotiate favorable contracts or renew existing contracts with third-party payors on favorable terms; significant changes in our payor mix or case mix resulting from fluctuations in the types of cases treated at our facilities; significant changes in the rules, regulations and systems governing Medicare and Medicaid reimbursements; material changes in IRS revenue rulings, case law or the interpretation of such rulings; shortages of, or quality control issues with, emergency care-related products, equipment and medical supplies that could result in a disruption of our operations; the intense competition we face for patients, physician use of our facilities, strategic relationships and commercial payor contracts; the fact that we are subject to significant malpractice and related legal claims; the growth of patient receivables or the deterioration in the ability to collect on those accounts; the impact on us of PPACA, which represents a significant change to the healthcare industry; and ensuring our continued compliance with HIPAA, which could require us to expend significant resources and capital; and the factors discussed in the section entitled "Risk Factors" in the Company's Form 10-K for the fiscal year ended December 31, 2015.

Non-GAAP Financial Measures Description and Reconciliation

This press release includes presentations of Adjusted EBITDA, which is defined as net income before interest, taxes, depreciation and amortization, further adjusted to eliminate the impact of certain additional items, including, facility preopening expenses, stock compensation expense and other non-recurring costs, losses or gains.

This press release also includes presentation of Adjusted earnings per share, which is defined as earnings per share related to the Company's overall operation, including controlling and non-controlling interests, as adjusted to exclude certain additional items, including, facility preopening expenses, stock compensation expense and other non-recurring costs, losses or gains and an adjustment for taxes in order to establish a normalized tax rate of 35% for comparability purposes, divided by the aggregate number of shares of Class A and Class B common stock outstanding as of the end of the period.

In addition, this press release presents systemwide metrics to analyze the results of operations. These systemwide metrics include systemwide net patient services revenue. Systemwide metrics treat our unconsolidated facilities as if they were consolidated.

These non-GAAP financial measures, Adjusted EBITDA, Adjusted earnings per share and systemwide metrics, are commonly used by management and investors as performance measures. The Company's non-GAAP financial measures are not considered measures of financial performance under U.S. generally accepted accounting principles (GAAP), and the items excluded therefrom are significant components in understanding and assessing our financial performance. These non-GAAP financial measures should not be considered in isolation or as an alternative to GAAP measures such as net income, cash flows provided by or used in operating, investing or financing activities or other financial statement data presented in our consolidated financial statements as an indicator of financial performance. Reconciliations of non-GAAP financial measures are provided in this press release. Since these non-GAAP financial measures are not measures determined in accordance with GAAP and are susceptible to varying calculations, these measures, as presented, may not be comparable to other similarly titled measures of other companies.




                                                                        Adeptus Health Inc.

                                               Condensed Consolidated Statements of Operations and Other Information

                                           (unaudited; in thousands, except shares, per share data and other information)


                                                                                                                            Three months ended

                                                                                                                                March 31,
                                                                                                                              ---------

                                                                                                                                2016                2015
                                                                                                                                ----                ----


    Patient service revenue                                                                                                 $133,288             $95,902

    Provision for bad debt                                                                                                  (27,053)           (14,945)
                                                                                                                             -------             -------

    Net patient service revenue                                                                                              106,235              80,957

    Management and contract services revenue                                                                                   6,534                 496
                                                                                                                               -----                 ---

    Total net operating revenue                                                                                              112,769              81,453

    Equity in earnings (loss) of unconsolidated joint ventures                                                                 2,501               (694)

    Operating expenses:

    Salaries, wages and benefits                                                                                              66,815              48,880

    General and administrative                                                                                                16,264              10,464

    Other operating expenses                                                                                                  15,013              11,305

    Depreciation and amortization                                                                                              4,371               4,756
                                                                                                                               -----               -----

    Total operating expenses                                                                                                 102,463              75,405
                                                                                                                             -------              ------

    Income from operations                                                                                                    12,807               5,354
                                                                                                                              ------               -----

    Other expense:

    Interest expense                                                                                                         (1,826)            (3,274)
                                                                                                                              ------              ------

    Total other expense                                                                                                      (1,826)            (3,274)
                                                                                                                              ------              ------

    Income before provision for income taxes                                                                                  10,981               2,080

    Provision for income taxes                                                                                                 3,118                 478
                                                                                                                               -----                 ---

    Net income                                                                                                                 7,863               1,602

    Less: Net income attributable to the non-controlling interest                                                              3,330               1,008
                                                                                                                               -----               -----

    Net income attributable to Adeptus Health Inc.                                                                            $4,533                $594
                                                                                                                              ======                ====

    Net income per share of Class A common stock:

    Basic                                                                                                                      $0.32               $0.06

    Diluted                                                                                                                    $0.32               $0.06

    Weighted average shares of Class A common stock:

    Basic                                                                                                                 14,373,699           9,906,845

    Diluted                                                                                                               14,373,699           9,906,845


    Other information

    Number of systemwide facilities, including two hospitals                                                                      90                  63


                    Adeptus Health Inc.

      Reconciliation of Adjusted EBITDA to Net Income

                 (unaudited; in thousands)


                                               Three months ended

                                                    March 31,
                                                  ---------

                                                  2016          2015
                                                  ----          ----


    Net income                                  $7,863        $1,602

    Depreciation and amortization(1)             4,808         4,756

    Interest expense                             1,826         3,274

    Provision for income taxes                   3,118           478

    Preopening expenses                          1,941         2,099

    Stock compensation expense                   1,088           549

    Duplicative billing effort                     208             -

    Other                                          887           505
                                                   ---           ---

    Total adjustments                           13,876        11,661
                                                ------        ------

    Adjusted EBITDA                            $21,739       $13,263
                                               =======       =======



    (1) Includes the Company's
     proportionate share of
     depreciation and amortization
     related to its joint ventures




                                                       Adjusted Earnings Per Share Reconciliation

                                     (unaudited; in thousands, except shares, per share data and other information)


                                                                                                                        Three months ended

                                                                                                                            March 31,
                                                                                                                            ---------

                                                                                                                          2016             2015
                                                                                                                          ----             ----

    Weighted average common shares outstanding

           Class A common shares                                                                                    14,373,699        9,906,845

           Class B common shares                                                                                     6,510,177       10,781,153
                                                                                                                     ---------       ----------

    Total Class A and B common shares                                                                               20,883,876       20,687,998


    Net income attributable to Adeptus Health Inc.                                                                      $4,533             $594

    Net income attributable to non-controlling interest                                                                  3,330            1,008
                                                                                                                         -----            -----

    Total net income                                                                                                     7,863            1,602


    Adjustments:

      Preopening expenses                                                                                                1,941            2,099

      Stock compensation expense                                                                                         1,088              549

      Duplicative billing effort                                                                                           208                -

      Other                                                                                                                887              505
                                                                                                                           ---              ---

      Total adjustments                                                                                                  4,124            3,153

      Tax impact of adjustments (1)                                                                                    (1,443)         (1,104)

      Tax adjustment resulting from applying effective tax rate (2)                                                      (725)           (250)
                                                                                                                          ----             ----

    Adjusted net income                                                                                                  9,819            3,401
                                                                                                                         -----            -----

    Adjusted net income per share                                                                                        $0.47            $0.16
                                                                                                                         =====            =====



    (1) Reflects the removal of the tax benefit associated with the adjustments

    (2) Represents adjusting to a normalized effective tax rate of 35%


                                                      Adeptus Health Inc.

                                            Systemwide Net Patient Services Revenue

                                                   (unaudited; in thousands)


                                                                                       Three months ended

                                                                                            March 31,
                                                                                          ---------

                                                                                    2016                  2015
                                                                                    ----                  ----

    Net Patient Services Revenue:

    Consolidated facilities                                                                  $106,235          $80,957

    Unconsolidated joint ventures                                                            34,125            3,004
                                                                                             ------            -----

    Systemwide net patient services revenue                                                  $140,360          $83,961
                                                                                             ========          =======




                                                                                                              Adeptus Health Inc.

                                                                                                     Condensed Consolidated Balance Sheets

                                                                                                                 (in thousands)


                                                                                                                                            March 31,           December 31,

                                                                                                                                                           2016                  2015
                                                                                                                                                           ----                  ----

    ASSETS                                                                                                                                 (unaudited)            (audited)

    Current assets

    Cash                                                                                                                                                 $3,656               $16,037

    Accounts receivable, less allowance for doubtful accounts of $38,880 and $28,818, respectively                                                       77,397                65,954

    Other receivables and current assets                                                                                                                 38,640                31,532

    Medical supplies inventory                                                                                                                            5,673                 5,167
                                                                                                                                                          -----                 -----

    Total current assets                                                                                                                                125,366               118,690

    Property and equipment, net                                                                                                                          68,303                70,187

    Investment in unconsolidated joint ventures                                                                                                          45,605                43,104

    Deposits                                                                                                                                              1,010                 1,163

    Deferred tax asset                                                                                                                                  204,491               206,265

    Intangibles, net                                                                                                                                     17,790                18,235

    Goodwill                                                                                                                                             61,009                61,009

    Other long term assets                                                                                                                                2,767                 2,950
                                                                                                                                                          -----                 -----

    Total assets                                                                                                                                       $526,341              $521,603
                                                                                                                                                       ========              ========


    LIABILITIES AND SHAREHOLDERS' EQUITY

    Current liabilities

    Accounts payable and accrued expenses                                                                                                               $28,494               $27,521

    Accrued compensation                                                                                                                                 20,137                23,197

    Current maturities of long-term debt                                                                                                                  6,910                 7,585

    Current maturities of capital lease obligations                                                                                                         107                   102

    Deferred rent                                                                                                                                           944                   858
                                                                                                                                                            ---                   ---

    Total current liabilities                                                                                                                            56,592                59,263

    Long-term debt, less current maturities                                                                                                             112,141               113,563

    Payable to related parties pursuant to tax receivable agreement                                                                                     191,302               191,302

    Capital lease obligation, less current maturities                                                                                                     3,925                 3,954

    Deferred rent                                                                                                                                         4,207                 3,837
                                                                                                                                                          -----                 -----

    Total liabilities                                                                                                                                   368,167               371,919
                                                                                                                                                        -------               -------

    Commitments and contingencies

    Shareholders' equity

    Preferred stock, par value $0.01 per share; 10,000,000 shares authorized and zero shares issued and outstanding at March 31,
     2016                                                                                                                                                     -                    -

    Class A common stock, par value $0.01 per share; 50,000,000 shares authorized, 14,565,716 and 14,257,187 shares issued and
     outstanding at March 31, 2016 and December 31, 2015, respectively                                                                                      146                   143

    Class B common stock, par value $0.01 per share; 20,000,000 shares authorized, 6,507,738 and 6,510,738 shares issued and
     outstanding at March 31, 2016 and December 31, 2015, respectively                                                                                       65                    65

    Additional paid in capital                                                                                                                           86,253                85,457

    Retained earnings                                                                                                                                    10,684                 6,323

    Non-controlling interest                                                                                                                             61,026                57,696
                                                                                                                                                         ------                ------

    Total equity                                                                                                                                        158,174               149,684
                                                                                                                                                        -------               -------

    Total liabilities and shareholders' equity                                                                                                         $526,341              $521,603
                                                                                                                                                       ========              ========


                                                                                Adeptus Health Inc.

                                                                  Condensed Consolidated Statements of Cash Flows

                                                                             (unaudited; in thousands)


                                                                                                                   Three months ended

                                                                                                                        March 31,
                                                                                                                      ---------

                                                                                                                      2016          2015
                                                                                                                      ----          ----

    Cash flows from operating activities:

    Net income                                                                                                      $7,863        $1,602

    Adjustments to reconcile net income to net cash used in operating activities:

         Loss from the disposal or impairment of assets                                                                  2             -

         Depreciation and amortization                                                                               4,371         4,756

         Deferred tax benefit                                                                                        1,774           255

         Amortization of deferred loan costs                                                                           193           219

         Provision for bad debts                                                                                    27,053        14,945

         Equity in (earnings) loss of unconsolidated joint ventures                                                (2,501)          694

         Stock-based compensation                                                                                    1,088           549

         Changes in operating assets and liabilities:

            Restricted cash                                                                                              -      (3,073)

            Accounts receivable                                                                                   (38,496)     (26,900)

            Other receivables and current assets                                                                   (7,108)        1,109

            Medical supplies inventory                                                                               (506)        (126)

            Other long-term assets                                                                                     183            17

            Accounts payable and accrued expenses                                                                    1,271       (7,004)

            Accrued compensation                                                                                   (3,060)          543

            Deferred rent                                                                                              456           453
                                                                                                                       ---           ---

    Net cash used in operating activities                                                                          (7,417)     (11,961)
                                                                                                                    ------       -------

    Cash flows from investing activities:

    Deposits                                                                                                           153           675

    Proceeds from the sale of property and equipment                                                                     -        1,517

    Capital expenditures                                                                                           (2,044)      (1,620)
                                                                                                                    ------        ------

              Net cash (used in) provided by investing activities                                                  (1,891)          572
                                                                                                                    ------           ---

    Cash flows from financing activities:

    Proceeds from long-term borrowings                                                                              14,000        24,000

    Payment of deferred loan costs                                                                                       -         (80)

    Payments on borrowings                                                                                        (16,290)        (642)

    Payments of capital lease obligations                                                                             (24)         (19)

    Restricted stock forfeited on vesting to satisfy withholding requirements                                        (587)            -

    Tax distribution to unit holders                                                                                 (172)            -
                                                                                                                      ----           ---

              Net cash (used in) provided by financing activities                                                  (3,073)       23,259
                                                                                                                    ------        ------

    Net (decrease) increase in cash and cash equivalents                                                          (12,381)       11,870

    Cash, beginning of period                                                                                       16,037         2,002
                                                                                                                    ------         -----

    Cash, end of period                                                                                             $3,656       $13,872
                                                                                                                    ======       =======

Logo - http://photos.prnewswire.com/prnh/20140625/121364

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/adeptus-health-reports-first-quarter-2016-results-300254214.html

SOURCE Adeptus Health Inc.